The company said, “Codexis (CDXS) expects that its existing cash, cash equivalents, and short-term investments will be sufficient to fund its planned operations through the end of 2027.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXS:
- Codexis (CDXS) Q1 Earnings Cheat Sheet
- Codexis Board Director Resignation and Governance Rebalancing Announced
- Codexis Earnings Call: ECOsynthesis Momentum Amid Risks
- Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
- Codexis: One-Off Merck Upside and siRNA Roadmap Support a Cautious Hold Rating